GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adherium Ltd (ASX:ADRDA) » Definitions » Common Stock

Adherium (ASX:ADRDA) Common Stock : A$131.57 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Adherium Common Stock?

Adherium's quarterly common stock increased from Dec. 2023 (A$123.65 Mil) to Jun. 2024 (A$131.00 Mil) and increased from Jun. 2024 (A$131.00 Mil) to Dec. 2024 (A$131.57 Mil).

Adherium's annual common stock increased from Jun. 2022 (A$110.52 Mil) to Jun. 2023 (A$123.62 Mil) and increased from Jun. 2023 (A$123.62 Mil) to Jun. 2024 (A$131.00 Mil).


Adherium Common Stock Historical Data

The historical data trend for Adherium's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adherium Common Stock Chart

Adherium Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Common Stock
Get a 7-Day Free Trial 87.68 110.17 110.52 123.62 131.00

Adherium Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 123.53 123.62 123.65 131.00 131.57

Adherium Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Adherium Business Description

Traded in Other Exchanges
N/A
Address
447 Collins Street, Level 5, Melbourne, VIC, AUS, 3000
Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. It is an international Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers. Its geographically segments include New Zealand and Australia, Europe, and North America. Maximum of it revenue is gained from Europe.

Adherium Headlines

No Headlines